- Academic Editor
-
-
-
Background: To evaluate the safety profiles and role
of antepartum transabdominal amnioinfusion (TA) in detecting fetal anomalies in
pregnant women with oligohydramnios during the second trimester.
Methods: Pregnant women with a diagnosis of oligohydramnios at 16 0/7 to
27 0/7 weeks of gestation were evaluated at our center between June 2014 and
April 2020. Data collected included maternal and fetal clinical characteristics,
ultrasonographic or magnetic resonance imaging findings, chromosomal results, and
perinatal mortality. Pregnancy outcomes and procedure-related complications were
then analyzed. Results: The study analyzed 106 pregnant women with
severe oligohydramnios, at a mean gestational age of 22